The CRISPR era is here – and we’re proud to be at the forefront. Thank you The Atlantic for inviting our CEO Dr. Samarth Kulkarni to the Atlantic Health Summit to discuss how CRISPR is pioneering a new era of medicine with potential applications for a range of serious diseases. #CRISPRTX #AtlanticHealth #Innovation
CRISPR Therapeutics’ Post
More Relevant Posts
-
𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials. ➡️ https://ow.ly/h5Rq50PF0T2 #VideoAbstract by Denisse Arellano and Augusto Santos jr. #ThisIsISN – Advancing kidney health worldwide. Together.
-
Most of the #rarediseases don’t have therapies due to lack of #clinicaltrials for rare conditions. The time is now for the #lifesciences industry to ramp up the research, innovate and come up with medical interventions for rare diseases. We can help expedite studies for such rare conditions with our best-in-industry clinical capabilities. Learn more: https://bit.ly/48xFFs4 #RareDiseaseDay2024 #ClinicalResearch
-
-
What a priviledge to be part of the Future of Medicine conference in Auckland listening and learning to other's research and stories as well as sharing mine! Good to be with likeminded providers, and bring validated for the work I do at Real Healthy Me. Good to be part of change, and priviledged to be equiped enough to help my patients/clients in their health journey in remissioning of chronic health conditions and cancer survivorship. #preventionisbetterthancure #personalisedmedicine #precisionmedicine
-
-
Over 2 billion people globally are living with chronic diseases. At Montai, we want to create a new paradigm to improve health outcomes for as many people as possible. Join our CEO Margo Georgiadis as she dives into this discussion at the HLTH panel, "Sometimes It's Your First Rodeo." She will share her insights on how to be a leader in the small molecule space and how technology is enabling breakthrough solutions by unlocking the therapeutic potential of chemical diversity that was previously untappable. Explore the #HLTH2023 agenda, including Margo's panel discussion: https://lnkd.in/gUuviu94 #thoughtleadership #womeninscience #artificialintelligence #drugdevelopment
-
-
Do you suffer from or have you received treatment for haemorrhoids? Help researchers develop a study around new treatments by sharing your experiences in a focus group. Express your interest before 25th August at this link: https://lnkd.in/gQKf2JJ3 #BowelResearch #CEDARCardiff #Haemorrhoids
-
-
How do you find the "true" prevalence of a rare disease? When epidemiological field studies are so expensive, we can screen electronic health records or other administrative datasets and obtain reasonable estimates by attempting to understand "undiagnosed prevalence". In the next on our series of whitepapers on #PBC, our consultant epidemiologist Michael Hughes explores practical methods of estimating "true" prevalence. ⬇️⬇️⬇️ Check it out below ⬇️⬇️⬇️ Scott Fletcher Thomas Babb Jamie Papasavvas #RareDiseases #HealthcareInnovation #PublicHealth #DataScience #PatientCare #HealthPolicy #Research #HealthcareProfessionals #PatientDiscovery #LifeSciences
Who knows the true prevalence of primary biliary cholangitis? Here's my thoughts on what the lower bound is, to set expectations for Real World Health's #PBC patient discovery research program.